02552

2.0150.98%
FT

Fuxing Tang

CTO, VP of Chemical Manufacturing Control Department and Head of R&D in USA

Dr. Fuxing Tang Ph.D., has been Chief Technology Officer, Vice President of Chemical Manufacturing Control department and Head of R&D in USA at Hua Medicine (Shanghai) Ltd since February 2020. Dr. Tang worked in the pharmaceutical industry and regulatory affairs. Dr. Tang worked as reviewer in the Office of Regulatory Science of the U.S. Food and Drug Administration, and worked in TEVA and Allergan as Global Director of Biopharmaceutical Sciences. Dr. Tang started his career at Forest labs, Inc. During his tenure at Forest labs, Inc/Allergan, Dr. Tang was instrumental in building various biopharmaceutical functions and in charge of multi-functions of ADME, preformulation, drug product process optimization and product post-approval manufacture process optimization. Dr. Tang obtained his Ph.D. in Pharmaceutical Sciences from the University of Florida. In addition, Dr. Tang conducted postdoctoral research in peptide delivery in Professor Ronald Borchardt’s group, which is well known for their work in Caco-2 cells.

Positions